These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24527965)

  • 1. Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment.
    Javelle E; Lightburne E; Dukan P; De Biasi C; Morand JJ
    Int J Dermatol; 2014 Apr; 53(4):487-9. PubMed ID: 24527965
    [No Abstract]   [Full Text] [Related]  

  • 2. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
    Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
    J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
    [No Abstract]   [Full Text] [Related]  

  • 3. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin.
    Pavan MH; Velho PE; Vigani AG; Gonçalves FL; Aoki FH
    Braz J Infect Dis; 2007 Jun; 11(3):383-4. PubMed ID: 17684645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic infections update.
    Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermodysplasia verruciformis and human immunodeficiency virus infection: a distinct entity?
    Daly ML; Hay RJ
    Curr Opin Infect Dis; 2012 Apr; 25(2):123-5. PubMed ID: 22274729
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired epidermodysplasia verruciformis in a child with the human immunodeficiency virus.
    Cowan KR; Gonzalez Santiago TM; Tollefson MM
    Pediatr Dermatol; 2013; 30(6):e252-4. PubMed ID: 23758597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 10. Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient.
    Haas N; Fuchs PG; Hermes B; Henz BM
    Br J Dermatol; 2001 Oct; 145(4):669-70. PubMed ID: 11703302
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular analysis of mixed infection with hepatitis C virus and human immunodeficiency virus in a patient infected simultaneously.
    Mazza C; Puoti M; Ravaggi A; Castelnuovo F; Albertini A; Cariani E
    J Med Virol; 1996 Nov; 50(3):276-82. PubMed ID: 8923294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C and HIV: ribavirin plus interferon study recruiting.
    AIDS Treat News; 1998 May; (No 295):5. PubMed ID: 11365407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No apparent effect of cidofovir in epidermodysplasia verruciformis.
    Preiser W; Kapur N; Snoeck R; Groves RW; Brink NS
    J Clin Virol; 2000 Feb; 16(1):55-7. PubMed ID: 10680741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha].
    Acero D; Adrados M; González-Huix F; Figa M
    Gastroenterol Hepatol; 1996 May; 19(5):243-6. PubMed ID: 8752565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homicidal ideation secondary to interferon.
    James CW; Savini CJ
    Ann Pharmacother; 2001; 35(7-8):962-3. PubMed ID: 11485154
    [No Abstract]   [Full Text] [Related]  

  • 16. Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
    Colson P; Bregigeon S; Tourres C; Solas C; Poizot-Martin I; Tamalet C
    J Clin Virol; 2013 Sep; 58(1):309-14. PubMed ID: 23810614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis? What is it?].
    Hernández ML
    Sidahora; 2002; (4):11-3. PubMed ID: 12703473
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].
    Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC
    Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.
    Levine AM; Shimodaira S; Lai MM
    N Engl J Med; 2003 Nov; 349(21):2078-9. PubMed ID: 14627800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of chronic hepatitis C infection in patients infected with the human immunodeficiency virus: from what we know to what we ignore].
    Torre-Cisneros J; Rivero A
    Med Clin (Barc); 2001 Jun; 116(20):775-8. PubMed ID: 11440683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.